Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michiel Coppens

Showing results (71-80 of 143) with videos related to

Pageof 15
Sort By:
Thrombosis Research|October 4, 2020
Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonistsRoisin Bavalia, Rahat Abdoellakhan, Ludo F Beenen, et al.
Annals of Hematology|April 13, 2011
Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the legMandy N Lauw, Erik W N Bus, Alexander F Y van Wulfften Palthe, et al.
Thrombosis and Haemostasis|August 28, 2007
The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defectsWillem M Lijfering, Michiel Coppens, Marlène H W van de Poel, et al.
Thrombosis and Haemostasis|January 17, 2025
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE EuropeGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 25, 2026
Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid SyndromeDagmar J M van Mourik, Manon Balvers, Valérie L B I Jansen, et al.
American Journal of Hematology|June 21, 2020
Bleeding phenotype and diagnostic characterization of patients with congenital platelet defectsMaaike W Blaauwgeers, Marieke J H A Kruip, Erik A M Beckers, et al.
Thrombosis and Haemostasis|September 20, 2021
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk ScoreMaria A de Winter, Jannick A N Dorresteijn, Walter Ageno, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2020
Congenital platelet disorders and health status-related quality of lifeMaaike W Blaauwgeers, Marieke J H A Kruip, Erik A M Beckers, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2024
Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia BNiamh O'Connell, Paul van der Valk, Sandra Le Quellec, et al.
The New England Journal of Medicine|December 8, 2025
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Wolfgang Miesbach, Michael Recht, et al.
Pageof 15

Showing results (71-80 of 143) with videos related to

Sort By:
Pageof 15
Thrombosis Research|October 4, 2020
Outcome of intracranial bleeding managed with prothrombin complex concentrate in patients on direct factor Xa inhibitors or vitamin K antagonistsRoisin Bavalia, Rahat Abdoellakhan, Ludo F Beenen, et al.
Annals of Hematology|April 13, 2011
Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the legMandy N Lauw, Erik W N Bus, Alexander F Y van Wulfften Palthe, et al.
Thrombosis and Haemostasis|August 28, 2007
The risk of venous and arterial thrombosis in hyperhomocysteinaemia is low and mainly depends on concomitant thrombophilic defectsWillem M Lijfering, Michiel Coppens, Marlène H W van de Poel, et al.
Thrombosis and Haemostasis|January 17, 2025
Treatment of Venous Thromboembolism with Edoxaban over 18 Months: Results from ETNA-VTE EuropeGiancarlo Agnelli, Ulrich Hoffmann, Philippe Hainaut, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|June 25, 2026
Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid SyndromeDagmar J M van Mourik, Manon Balvers, Valérie L B I Jansen, et al.
American Journal of Hematology|June 21, 2020
Bleeding phenotype and diagnostic characterization of patients with congenital platelet defectsMaaike W Blaauwgeers, Marieke J H A Kruip, Erik A M Beckers, et al.
Thrombosis and Haemostasis|September 20, 2021
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk ScoreMaria A de Winter, Jannick A N Dorresteijn, Walter Ageno, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2020
Congenital platelet disorders and health status-related quality of lifeMaaike W Blaauwgeers, Marieke J H A Kruip, Erik A M Beckers, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2024
Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia BNiamh O'Connell, Paul van der Valk, Sandra Le Quellec, et al.
The New England Journal of Medicine|December 8, 2025
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Wolfgang Miesbach, Michael Recht, et al.
Pageof 15